This innovation enhances viral stability, preserves potency, and reduces allergic reactions and antigen crystallisation-related issues
The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of June 10, 2026
This drug candidate, which is currently progressing through pivotal clinical studies, has the potential to become the first add-on therapy for schizophrenia patients who do not respond adequately
Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale
The company announced that it has been granted patent covering “Substituted Ethylamine Fused Heterocyclic Mescaline Derivatives.”
The portfolio includes foundational patents on the production, composition, and commercial use of NR
This new facility strengthens Latin America as a collaborative hub
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients
Centre for Continuous Manufacturing and Advanced Crystallisation (CMAC) aims to accelerate the digital transformation of CMC development and manufacturing approaches
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
